Interactions on record — worth a quick check against your medications. Check your meds →
Dietary supplement

PheniTropic Ingredients & Drug Interactions

by Biotics Research Corporation

Capsule Category: Non-nutrient/non-botanical
Most serious interaction: Moderate
The interaction bottom line Most serious interaction: Moderate

PheniTropic is a dietary supplement by Biotics Research Corporation with 1 active ingredient. Its ingredients are commonly taken for anxiety and stress, insomnia and sleep problems, stress relief.Based on those ingredients, 248 medications have a known interaction with it, the most serious rated moderate. The ingredients most likely to interact are Phenibut. Use the checker below to test your specific medication, or read the full HelloPharmacist Interaction Report.

HelloPharmacist Scorecard of PheniTropic by Biotics Research Corporation

Our pharmacy team’s full take, with four database checks built into the cards below — a summary of what is known, not a grade of the product itself.

From our pharmacy team — supplement deep dive

What’s inside

Full disclosure
Ingredient Transparency · database check
Full

Every active ingredient lists its own amount on the label.

Why this rating?
  • The label discloses an exact amount for 1 of its 1 active ingredient.
  • No proprietary blends here — you can verify the dose of every single component.

PheniTropic contains one active ingredient: phenibut, a compound that affects GABA receptors in the brain. The product also includes inactive ingredients — a capsule shell, microcrystalline cellulose (a filler), and magnesium stearate (a lubricant).

Does it work?

Insufficient evidence
Evidence for Intended Use · database check
By FDA rules, dietary supplements can’t claim to treat, cure, or prevent disease — so labels speak in careful marketing language. We discern each product’s intended use from its name, label claims, and label statements, then grade the clinical evidence for that use. How these ratings are computed
Insufficient

There isn't enough reliable clinical evidence to rate this product's ingredients for its stated purpose.

Why this rating?
  • The label markets this product for: anxiety and stress relief, mood and focus.
  • We looked for evidence on: Anxiety, Insomnia, Depression, stress, sleep quality, emotional well-being.
  • The closest evidence on file: Phenibut is rated "Insufficient Reliable Evidence To Rate" for Anxiety (Natural Medicines).
  • Also on file: Phenibut is rated "Insufficient Reliable Evidence To Rate" for Depression, Insomnia, Post-traumatic stress disorder (PTSD).

The evidence we hold does not establish that phenibut is effective for alcohol use disorder, anxiety, ADHD, cognitive function, depression, or insomnia. All six conditions show insufficient reliable evidence to rate it.

This doesn't mean it doesn't work — it means the data available to us isn't strong enough to say either way.

The evidence, ingredient by ingredient Phenibut

How safe is it?

Well-documented data
Safety Information · database check
Well characterized

Adverse-effect, pregnancy, and general safety data are on file for most of these ingredients.

Why this rating?
  • We hold adverse-effect (side-effect) data for 1 of the 1 matched ingredient.
  • Pregnancy & breastfeeding safety ratings cover 1 of 1.
  • General safety write-ups exist for 1 of 1.
  • Remember: this measures how much safety information exists. Thin data is not the same as being safe.

Phenibut is regarded as unsafe when taken by mouth. The most common side effects include dizziness, drowsiness, nausea, and balance problems.

More concerning, phenibut carries a high risk of dependence: tolerance can develop within 3 days, and stopping after even a few days of use can trigger serious withdrawal symptoms including seizures, hallucinations, high blood pressure, and rapid heart rate. Case reports also link phenibut to agitation, aggression, altered mental status, and respiratory depression, especially at high doses.

Because there is no safety data in pregnancy and phenibut is a central nervous system depressant, it should be avoided during pregnancy. It's also unknown whether it passes into breast milk, so it should be avoided while breastfeeding.

Side effects, ingredient by ingredient Phenibut

Meds to double-check

Moderate interaction found
Known Interaction Concern · database check
Moderate identified

The most serious documented interaction for these ingredients is Moderate. Check your medications for a personalized result.

Why this rating?
  • 1 of the 1 matched ingredient can interact with medications — Phenibut.
  • The most serious interaction on file is rated Moderate.
  • For scale: 248 individual medications appear in the full list. A big number alone doesn't make a product dangerous — what matters is whether YOUR medication is on it, so run yours through the interaction checker on this page.

Before taking this product, check any medications you use that depress your central nervous system — sedatives, sleep aids, anxiety medications, pain relievers, and others — and pregabalin (Lyrica) in particular. These carry Moderate risk of increased sedation and breathing problems when combined with phenibut.

Check your own medication Run your meds through the checker above

The bottom line

Scorecard at a glanceFully disclosed formula with insufficient evidence for its stated purpose. Moderate medication interactions have been identified, and safety information is well characterized.

Phenibut is not approved as a supplement or drug in the U.S., carries a serious risk of dependence and dangerous withdrawal, and has no established evidence of effectiveness for the conditions marketed. We'd advise talking with your pharmacist or doctor before using this product, especially if you take any medications that affect your central nervous system.

Educational only — not medical advice; always confirm with your pharmacist. Our editorial policy · How we use AI

Assessment coverage: 1 of 1 active ingredient matched to our full ingredient reviews (monographs). Based on the product label dated May 24, 2013.

This Scorecard evaluates available label information, ingredient evidence, and known medication-safety considerations. It does not independently verify product identity, purity, potency, contamination, or manufacturing quality. How these ratings are computed

At a glance

General information

Key facts about PheniTropic, straight from the product label.

Brand Biotics Research Corporation
Net contents 60 Capsule(s)
Market status On market
Date entered into DSLD May 24, 2013
DSLD ID 21971
Product type Non-nutrient/non-botanical
Supplement form Capsule
Dietary claims / uses All Other
Intended target group(s) Adult (18 - 50 Years)
From the label
Everything in this section is reproduced from the manufacturer’s own product label — it’s the label speaking, not HelloPharmacist. We show it so you can see exactly what the maker states; we don’t verify or endorse those statements.

Supplement Facts

The label details for PheniTropic by Biotics Research Corporation, sourced from the NIH Dietary Supplement Label Database.

Supplement Facts

Daily Value (DV) Target Group(s):
Adults and children 4 or more years of age
Minimum serving Sizes:
1 Capsule(s)
Maximum serving Sizes:
2 Capsule(s)
IngredientAmount% DV
Phenibut300 mg--

Other ingredients: Capsule shell, Microcrystalline Cellulose, Magnesium Stearate

Tap any ingredient to jump to its full detail below.

Label statements
These statements are the manufacturer’s wording, reproduced from the product label — the label is saying it, not HelloPharmacist. We don’t verify or endorse them.
Suggested/Recommended/Usage/Directions

RECOMMENDATION: One (1) capsule taken one (1) to two (2) times each day as a dietary supplement or as otherwise directed by a healthcare professional.

Precautions

Caution: Not recommended for pregnant or lactating women. Not intended to be mixed with sedatives. Those taking monoamine oxidase inhibitors should consult with their physicians.

KEEP OUT OF REACH OF CHILDREN

Sealed with an imprinted safety seal for your protection.

Storage

Store in a cool, dry area.

General

Rev. 04/11

FDA Statement of Identity

Dietary Supplement

Seals/Symbols

{recycle} Please Recycle

General Statements

Lot Number: Exp. Date:

Brand IP Statement(s)

(C) Copyright 2006

See for yourself

PheniTropic by Biotics Research Corporation label

The label scan from the NIH Dietary Supplement Label Database. Tap to enlarge.

What’s inside

The Ingredients in PheniTropic by Biotics Research Corporation

This is the 1 active ingredient this product is made of. Select it to open its full monograph.

Serving size1 Capsule(s) Dosage formCapsule Amounts shown are per serving.

Phenibut

Interacts with
248 drugs
300 mg per serving

Phenibut is a synthetic, lab-made central nervous system depressant—not a natural herb—that some people use for anxiety and sleep, but it carries a se...

Phenibut monograph & interactions

Other (inactive) ingredients: Capsule shell, Microcrystalline Cellulose, Magnesium Stearate. These complete the product’s ingredient list but are not active constituents.

Interaction report

PheniTropic by Biotics Research Corporation Drug Interactions

Want to check YOUR meds against PheniTropic?

Ask about interactions with your drugs in plain English — “Can I take it with lisinopril?” — and we find you the answer in seconds, ingredient by ingredient.

Go to the checker
248Drugs
248 Moderate

Ingredients driving the most interactions

Phenibut 248

Each ingredient & the kinds of drugs it affects

For each ingredient in PheniTropic with known interactions, here are the types of medications it can affect. Open any type for the detail — or search your exact drug in the checker above.

Phenibut2 drug types · 248 drugs

Cns Depressants

Theoretically, phenibut might increase the risk of sedation and respiratory depression when taken with CNS depressants.
Phenibut has been associated with sedation and respiratory depression in several case reports, especially when taken at high doses.

Likelihood Possible Evidence D
Pregabalin (Lyrica)

Theoretically, phenibut might increase the risk for additive adverse effects, including sedation, when taken with pregabalin.
Phenibut is structurally related to pregabalin, and both chemicals act at GABA receptors in the brain. In a case report, a patient who had experienced tolerance to the effects of pregabalin for treatment of chronic neuropathic pain experienced a reduction in tolerance when phenibut was taken concurrently.

Likelihood Possible Evidence D
The maker

Brand information

Manufacturer and brand details for PheniTropic, from the product label.

Biotics Research Corporation

See all Biotics Research Corporation products
Name
BIOTICS RESEARCH CORP.
City
Rosenberg
State
Texas
Phone Number
(281) 344-0909
Pharmacist Counseling Corner

PheniTropic by Biotics Research Corporation: Common Questions

Does PheniTropic by Biotics Research Corporation interact with any medications?
Yes. Based on its ingredients, PheniTropic has a known interaction with 248 medications. Use the checker to see how it interacts with a specific drug.
How can one product interact with so many drugs?
PheniTropic contains a single active ingredient, and that one ingredient can interact with many different medications on its own. We check it against each medication and show the mechanism responsible.
Where does this information come from?
The product label data comes from the NIH Dietary Supplement Label Database (DSLD); the interaction data is built on the Natural Medicines database and reviewed by HelloPharmacist pharmacists.
Is phenibut safe to use while pregnant or breastfeeding?
No. There is no safety data for phenibut in pregnancy and it is a central nervous system depressant, so it should be avoided during pregnancy. It's also unknown whether it passes into breast milk, so it should be avoided while breastfeeding. Talk with your doctor for personalized advice.
Can I stop taking phenibut whenever I want?
Phenibut carries a high risk of dependence. Withdrawal symptoms — including seizures, hallucinations, anxiety, and high blood pressure — can occur after just 3 or more consecutive days of use. If you've been taking it regularly, do not stop abruptly without talking to your pharmacist or doctor.
What are the most common side effects?
Dizziness, drowsiness, nausea, lethargy, and balance problems are the most common. More serious side effects reported in case studies include agitation, hallucinations, aggression, and respiratory depression, especially at high doses.
Does phenibut actually work for anxiety or sleep?
We don't have reliable evidence to say whether it works for anxiety, insomnia, or the other uses it's marketed for. The research available to us is insufficient to establish effectiveness.
Why is phenibut not approved in the U.S.?
Phenibut is not approved as a supplement or drug in the U.S. because of the high risk of dependence, dangerous withdrawal effects, and overdose. The safety profile doesn't support approval here.

Written and reviewed by the HelloPharmacist editorial staff. Our editorial policy

Not sure if PheniTropic is safe with your meds?

Our pharmacists answer your medication & supplement questions — free.

Ask a pharmacist

Label information is sourced from the NIH Dietary Supplement Label Database and reflects the product version on file; always read your actual product label. This page is for education only and is not a substitute for professional medical advice. Confirm with your pharmacist or doctor before combining supplements and medications.

PheniTropic label
Sources

Sources & How We Checked

PheniTropic's label data comes from the NIH Dietary Supplement Label Database; the ingredient interaction data is from the Natural Medicines database, reviewed by our pharmacists.

Content is written and reviewed by licensed HelloPharmacist pharmacists. See our data sources and editorial standards for how this information is built and checked.

The 23 references behind this product’s interaction data

Every citation that drives the interaction findings for this product’s ingredients, from the evidence-graded Natural Medicines (TRC Healthcare) database. Open an ingredient to browse its citations — links open the study on PubMed or the publisher’s site.

Phenibut 23 references
  1. Downes MA, Berling IL, Mostafa A, Grice J, Roberts MS, Isbister GK. Acute behavioural disturbance associated with phenibut purchased via an internet supplier. Clin Toxicol (Phila). 2015;53(7):636-8. PubMed
  2. Samokhvalov AV, Paton-Gay CL, Balchand K, Rehm J. Phenibut dependence. BMJ Case Rep. 2013 Feb 6;2013. Pii: bcr2012008381.
  3. O'Connell CW, Schneir AB, Hwang JQ, Cantrell FL. Phenibut, the appearance of another potentially dangerous product in the United States. Am J Med. 2014 Aug;127(8):e3-4. PubMed
  4. Brunner E, Levy R. Case report of physiologic phenibut dependence treated with a phenobarbital taper in a patient being treated with buprenorphine. J Addict Med. 2017 May/Jun;11(3):239-40. PubMed
  5. Sankary S, Canino P, Jackson J. Phenibut overdose. AM J Emerg Med. 2017 Mar;35(3):516.e1-516.e2.
  6. Owen DR, Wood DM, Archer JR, Dargan PI. Phenibut (4-amino-3-phenyl-butyric acid): Availability, prevalence of use, desired effects, and acute toxicity. Drug Alcohol Rev. 2016 Sep;35(5):591-6. PubMed
  7. Magsalin RM, Khan AY. Withdrawal symptoms after internet purchase of phenibut (beta-phenyl-gamma-aminobutyric acid HCl). J Clin Psychopharmacol. 2010 Oct;30(5):648-9.
  8. Rod W, Kudryk A, Brunetti L, Sun N, Nguyen M. Phenibut withdrawal management in the setting of concomitant kratom and alcohol dependence. Critical Care Med 2018;46(1):451.
  9. Li W, Madhira B. Phenibut (beta-phenyl-gamma-aminobutyric acid) psychosis. Am J Therapeut 2017;24(5):e639-640.
  10. Joshi Y, Friend S, Jimenez B, Steiger L. Dissociative intoxication and prolonged withdrawal associated with phenibut: a case report. J Clin Psychopharmacol 2017;37(4):478-80. PubMed
  11. Zheng KH, Khan A, Espiridion ED. Phenibut addiction in a patient with substance use disorder. Cureus. 2019;11(7):e5230. PubMed
  12. Hardman MI, Sprung J, Weingarten TN. Acute phenibut withdrawal: A comprehensive literature review and illustrative case report. Bosn J Basic Med Sci. 2019;19(2):125-129. PubMed
  13. Ahuja T, Mgbako O, Katzman C, Grossman A. Phenibut (β-Phenyl-γ-aminobutyric Acid) dependence and management of withdrawal: Emerging nootropics of abuse. Case Rep Psychiatry. 2018;2018:9864285.
  14. Isoardi KZ, Kulawickrama S, Isbister GK. Severe phenibut poisoning: An adolescent case cluster. J Paediatr Child Health. 2020;56(2):330-331. PubMed
  15. McCabe DJ, Bangh SA, Arens AM, Cole JB. Phenibut exposures and clinical effects reported to a regional poison center. Am J Emerg Med. 2019;37(11):2066-2071. PubMed
  16. Graves JM, Dilley J, Kubsad S, Liebelt E. Notes from the field: phenibut exposures reported to poison centers - United States, 2009-2019. MMWR Morb Mortal Wkly Rep 2020;69(35):1227-8. PubMed
  17. Tamarelli C, Hosanagar A. Phenibut use in a patient prescribed gabapentinoids (letter). Pain Med 2020; Aug 4:pnaa205. doi: 10.1093/pm/pnaa205. PubMed
  18. Esposito CM, Mandolini GM, Delvecchio G, Fiorentini A, Brambilla P. Psychomotor agitation non-responsive to treatment: a case report of phenibut withdrawal syndrome. Front Psychiatry 2021;12:688147. PubMed
  19. Acosta E, Munguti C. Acute Psychosis Associated with Phenibut Ingestion. Kans J Med 2021;14:308-309. PubMed
  20. VanDreese B, Holland A, Murray A. Chronic Phenibut Use: Symptoms, Severe Withdrawal, and Recovery. WMJ 2022;121(1):E1-E4.
  21. Martin R, Buffenstein I, Cho D, Kiyokawa M. Toxidrome of an Easily Obtainable Nootropic: A Case Report of Phenibut Intoxication and Withdrawal Delirium. J Clin Psychopharmacol 2023. PubMed
  22. Morris M, Espinosa J, Lucerna A, Lahr R. A case of phenibut withdrawal and treatment with baclofen. World J Emerg Med 2023;14(4):338-340. PubMed
  23. DiFiore E, Pittman J. A Case of Phenibut Withdrawal Management and Detoxification Using Baclofen in the Outpatient Setting. Case Rep Psychiatry 2024;2024:8824770. PubMed

See these in context on the Phenibut monograph →

Parts of this content are provided by the Therapeutic Research Center, LLC.

DISCLAIMER: Currently this does not check for drug-drug interactions. This is not an all-inclusive comprehensive list of potential interactions and is for informational purposes only. Not all interactions are known or well-reported in the scientific literature, and new interactions are continually being reported. Input is needed from a qualified healthcare provider including a pharmacist before starting any therapy. Application of clinical judgment is necessary.

© 2021 Therapeutic Research Center, LLC

Keep exploring